These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drug-Induced Tendon Disorders. Knobloch K Adv Exp Med Biol; 2016; 920():229-38. PubMed ID: 27535265 [TBL] [Abstract][Full Text] [Related]
25. Tendon rupture and statin therapy: is there a link? Comment on the article by Marie et al. Beri A; Khattri S Arthritis Rheum; 2008 Aug; 59(8):1202; author reply 1202. PubMed ID: 18668581 [No Abstract] [Full Text] [Related]
26. Tendon Injury and Fluoroquinolone Use: A Systematic Review. Stephenson AL; Wu W; Cortes D; Rochon PA Drug Saf; 2013 Sep; 36(9):709-21. PubMed ID: 23888427 [TBL] [Abstract][Full Text] [Related]
27. [Tendinitis by quinolones: treatment and drug class effect in two new cases]. Rodríguez-Vera FJ; Pereira Vega A; Pujol de la Llave E Rev Clin Esp; 2004 Jan; 204(1):35-6. PubMed ID: 14746761 [No Abstract] [Full Text] [Related]
28. Fluoroquinolones and tendon disorders. Melhus A Expert Opin Drug Saf; 2005 Mar; 4(2):299-309. PubMed ID: 15794721 [TBL] [Abstract][Full Text] [Related]
29. [Achilles tendinitis induced by pefloxacin. Apropos of 2 cases]. Blanche P; Sereni D; Sicard D; Christoforov B Ann Med Interne (Paris); 1992; 143(5):348. PubMed ID: 1482040 [No Abstract] [Full Text] [Related]
30. An elderly patient with fluoroquinolone-associated achilles tendinitis. Damuth E; Heidelbaugh J; Malani PN; Cinti SK Am J Geriatr Pharmacother; 2008 Dec; 6(5):264-8. PubMed ID: 19161929 [TBL] [Abstract][Full Text] [Related]
31. [Tendinopathy associated with fluoroquinolones: individuals at risk, incriminated physiopathologic mechanisms, therapeutic management]. Saint F; Salomon L; Cicco A; de la Taille A; Chopin D; Abbou CC Prog Urol; 2001 Dec; 11(6):1331-4. PubMed ID: 11859676 [TBL] [Abstract][Full Text] [Related]
32. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis. Johnson JL; Loomis IB Pharmacotherapy; 2006 Mar; 26(3):414-22. PubMed ID: 16503723 [TBL] [Abstract][Full Text] [Related]
35. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use. Fraunfelder FW; Richards AB Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555 [TBL] [Abstract][Full Text] [Related]
36. Safety concerns with fluoroquinolones. Mehlhorn AJ; Brown DA Ann Pharmacother; 2007 Nov; 41(11):1859-66. PubMed ID: 17911203 [TBL] [Abstract][Full Text] [Related]
37. [Fluoroquinolones-induced tendinitis: shoulder is not under shelter]. Salem R; Aouam K; Hafsa C; Kriaa S; Jerbi S; Golli M; Gannouni A; Boughattas NA Therapie; 2006; 61(1):73-4. PubMed ID: 16792158 [No Abstract] [Full Text] [Related]
38. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Seeger JD; West WA; Fife D; Noel GJ; Johnson LN; Walker AM Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):784-92. PubMed ID: 16456878 [TBL] [Abstract][Full Text] [Related]
39. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]